CompaniesSymbio Pharmaceuticals

Symbio Pharmaceuticals

active
Tokyo, Japan
Founded 2005
Website
About

Small Molecules

Areas of Focus

Categories

Small Molecule PharmaceuticalJapan
Clinical Trials (24)
View all

Total Trials

24

As Lead Sponsor

24

As Collaborator

0

Total Enrollment

737

By Phase

PHASE1/PHASE2: 2PHASE2: 9PHASE1: 10PHASE3: 2

By Status

COMPLETED: 18TERMINATED: 3RECRUITING: 2WITHDRAWN: 1
Clinical Trials Pipeline24 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
NCT01179490
NCT04706923
NCT06761677
Hover over trial bars to see details

Recent Trials

NCT06761677Lead Sponsor
A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma
PHASE1/PHASE2Recruiting
43 participants
Started: Jun 9, 2025 · Completed: May 8, 2029
NCT05511779Lead Sponsor
Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney Transplantation
PHASE2Terminated
1 participants
Started: Oct 14, 2022 · Completed: Apr 13, 2023
NCT04706923Lead Sponsor
A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection
PHASE2Recruiting
52 participants
Started: Aug 16, 2021 · Completed: Sep 30, 2026
NCT04542252Lead Sponsor
Drug-Drug Interaction Study of Intravenous Administration of SyB V-1901 and Cyclosporine in Japanese Healthy Subjects
PHASE1Completed
13 participants
Started: Nov 9, 2020 · Completed: Jan 29, 2021
NCT04354402Lead Sponsor
Follow-up Study of SyB L-0501 in Combination With Rituximab to Treat DLBCL
N/ACompleted
25 participants
Started: Mar 26, 2020 · Completed: Nov 11, 2020
View all 24 trials →
Locations (1)
Headquarters
Tokyo, Japan
Map

Loading map...